Kazia Therapeutics Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +11.8% | +119.9% | +9.4% | -29.9% | +0.0% | +16.7% | +47.7% | +0.0% | +0.0% | -50.0% | |
| – | – | – | +39.0% | -68.1% | +49.1% | +6.5% | +143.1% | +163.0% | -30.8% | -54.0% | +22.5% | |
| – | -118.8% | – | +1,024.5% | -425.8% | – | -57.3% | +302.3% | -99.0% | -2,484.9% | – | – | |
| – | +131.6% | -165.2% | – | – | -77.0% | +372.8% | -435.0% | – | +402.6% | +130.9% | -130.1% | |
| – | +261.3% | +438.6% | -97.8% | -100.0% | – | – | – | – | – | – | – | |
| – | +232.4% | +482.1% | +1,263.5% | – | +1,472.7% | -200.2% | +0.0% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | -98.3% | -100.0% | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | +762.1% | -98.4% | -102.3% | – | +0.0% | +218.1% | +131.5% | -86.7% | +248.1% | -53.9% | +167.0% | |
| – | – | -126.1% | – | – | – | – | +465.3% | -207.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.